17424
EPI-001 is being developed by the pharmaceutical company ESSA Pharma Inc ( Vancouver , Canada ) for the treatment of castration-resistant prostate cancer and is currently in pre-clinical development .
 None
Please list all entity words in the text that fit the category. Output format is "word1, word2". 
Option: location, person, organization 
Text: {0} 
Answer:
 None